The landscape of dementia analysis has progressed radically with the advent of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-centered exams which will detect Alzheimer's pathology years ahead of indications emerge. Although these technological advancements stand for exceptional progress in being familiar with neurodegenerative d